Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$42.07 +0.86 (+2.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Long-Term Debt Repayments (2012 - 2021)

Updated

Supernus Pharmaceuticals (SUPN) posted Long-Term Debt Repayments of $402.5 million for FY2023.

Analysis

Supernus Pharmaceuticals (SUPN) Long-Term Debt Repayments (2012 - 2021) Analysis & Trends

Since FY2012, Supernus Pharmaceuticals has reported Long-Term Debt Repayments for 4 years.

  • The FY2023 figure stands as the lowest annual Long-Term Debt Repayments since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Supernus Pharmaceuticals 2.42 Bn 1.07 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 138.32 Mn
Dec 31, 2020 -1.06 Mn
Mar 31, 2014 1,000.00
Dec 31, 2013 1.73 Mn
Jun 30, 2013 19.60 Mn
Mar 31, 2013 2.83 Mn
Dec 31, 2012 2.76 Mn
Sep 30, 2012 2.25 Mn
Jun 30, 2012 1.33 Mn
Mar 31, 2012 437,000.00
API Access

Supernus Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SUPN&period=max&api_key=YOUR_API_KEY